POMC and neoplasm: To test potential effects of MEK-162 treatment on in vitro corticotroph tumor cell growth and ACTH secretion, murine pituitary corticotroph tumor AtT20 cells were treated with MEK-162 ranging from 10 μM to 160 μM for 1 to 5 days.